Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Soria

Showing results (11-20 of 281) with videos related to

Pageof 29
Sort By:
Expert Opinion on Pharmacotherapy|May 14, 2019
Drug strategies for bladder cancer in the elderly: is there promise for the future?Francesco Soria, Alessandra Mosca, Paolo Gontero
European Urology Focus|April 2, 2023
A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non-muscle-invasive Bladder Cancer: ConPaolo Gontero, Simone Livoti, Francesco Soria
International Journal of Urology : Official Journal of the Japanese Urological Association|November 15, 2023
Editorial comment-Risk stratification and management of nonmuscle-invasive bladder cancer: A physician survey in six Asia-Pacific territoriesMatteo Rosazza, Francesco Soria, Paolo Gontero
Current Opinion in Urology|July 18, 2022
Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancerFrancesco Soria, Daniele Dutto, Paolo Gontero
European Urology|August 4, 2018
Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 TrialDavid D'Andrea, Shahrokh F Shariat, Francesco Soria
Current Opinion in Urology|August 21, 2018
Retreatment after focal therapy for failure: a bridge too far?Francesco Soria, Giancarlo Marra, Marco Allasia, et al.
European Urology|July 25, 2024
Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 TrialStefano Mancon, Francesco Soria, Benjamin Pradere, et al.
Current Opinion in Urology|February 15, 2019
Salvage therapeutic strategies for bacillus Calmette-Guerin failureMelanie R Hassler, Shahrokh F Shariat, Francesco Soria
Expert Review of Anticancer Therapy|December 30, 2015
Hyperthermia for non-muscle invasive bladder cancerFrancesco Soria, Marco Allasia, Marco Oderda, et al.
Expert Opinion on Pharmacotherapy|August 6, 2024
Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancerDaniele Dutto, Simone Livoti, Francesco Soria, et al.
Pageof 29

Showing results (11-20 of 281) with videos related to

Sort By:
Pageof 29
Expert Opinion on Pharmacotherapy|May 14, 2019
Drug strategies for bladder cancer in the elderly: is there promise for the future?Francesco Soria, Alessandra Mosca, Paolo Gontero
European Urology Focus|April 2, 2023
A Restaging Transurethral Resection of the Bladder Is Always Necessary for High-grade T1 Non-muscle-invasive Bladder Cancer: ConPaolo Gontero, Simone Livoti, Francesco Soria
International Journal of Urology : Official Journal of the Japanese Urological Association|November 15, 2023
Editorial comment-Risk stratification and management of nonmuscle-invasive bladder cancer: A physician survey in six Asia-Pacific territoriesMatteo Rosazza, Francesco Soria, Paolo Gontero
Current Opinion in Urology|July 18, 2022
Clinical and biological markers for risk-stratification of T1 high-grade non-muscle invasive bladder cancerFrancesco Soria, Daniele Dutto, Paolo Gontero
European Urology|August 4, 2018
Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 TrialDavid D'Andrea, Shahrokh F Shariat, Francesco Soria
Current Opinion in Urology|August 21, 2018
Retreatment after focal therapy for failure: a bridge too far?Francesco Soria, Giancarlo Marra, Marco Allasia, et al.
European Urology|July 25, 2024
Re: Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 TrialStefano Mancon, Francesco Soria, Benjamin Pradere, et al.
Current Opinion in Urology|February 15, 2019
Salvage therapeutic strategies for bacillus Calmette-Guerin failureMelanie R Hassler, Shahrokh F Shariat, Francesco Soria
Expert Review of Anticancer Therapy|December 30, 2015
Hyperthermia for non-muscle invasive bladder cancerFrancesco Soria, Marco Allasia, Marco Oderda, et al.
Expert Opinion on Pharmacotherapy|August 6, 2024
Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancerDaniele Dutto, Simone Livoti, Francesco Soria, et al.
Pageof 29